Carbamoyl phosphate synthetase (CPS) from Escherichia coli catalyzes the formation of carbamoyl phosphate, which is subsequently employed in both the pyrimidine and arginine biosynthetic pathways. The reaction mechanism is known to proceed through at least three highly reactive intermediates: ammonia, carboxyphosphate, and carbamate. In keeping with the fact that the product of CPS is utilized in two competing metabolic pathways, the enzyme is highly regulated by a variety of effector molecules including potassium and ornithine, which function as activators, and UMP, which acts as an inhibitor. IMP is also known to bind to CPS but the actual effect of this ligand on the activity of the enzyme is dependent upon both temperature and assay conditions. Here we describe the three-dimensional architecture of CPS with bound IMP determined and refined to 2.1 Å resolution. The nucleotide is situated at the C-terminal portion of a five-stranded parallel ␤-sheet in the allosteric domain formed by Ser 937 to Lys 1073 . Those amino acid side chains responsible for anchoring the nucleotide to the polypeptide chain include Lys 954 , Thr 974 , Thr 977 , Lys 993 , Asn 1015 , and Thr 1017 . A series of hydrogen bonds connect the IMP-binding pocket to the active site of the large subunit known to function in the phosphorylation of the unstable intermediate, carbamate. This structural analysis reveals, for the first time, the detailed manner in which CPS accommodates nucleotide monophosphate effector molecules within the allosteric domain.
Carbamoyl phosphate synthetase (CPS) 1 is one of the few allosterically regulated enzymes whose three-dimensional structure is now known to high resolution (1, 2) . A list of other regulated proteins, whose molecular architectures are known in quite extensive detail, includes phosphofructokinase (3), aspartate transcarbamoylase (4), glutamine synthetase (5) , and glycogen phosphorylase (6) , among others. The biochemical role of CPS is to catalyze the formation of carbamoyl phosphate, an unstable precursor that initiates subsequent steps in the biosynthesis of both pyrimidine nucleotides and arginine. The end-product of the pyrimidine biosynthetic pathway, UMP, allosterically inhibits this enzyme. Conversely, ornithine, the co-substrate with carbamoyl phosphate in the next step of the arginine biosynthetic pathway, enhances the catalytic activity of CPS. Each of these effectors primarily, but not exclusively, modulates the activity of CPS by raising or lowering the dissociation constant for Mg 2ϩ ATP by approximately one order of magnitude (7, 8) .
As isolated from E. coli, CPS is a large multidomain heterodimeric protein. The smaller of the two subunits has a molecular weight of ϳ42,000 and is catalytically responsible for the hydrolysis of glutamine and the subsequent translocation of the ammonia product to the large subunit (9) . The larger subunit (molecular weight ϳ118,000) is composed of four major regions as indicated in Fig. 1 (1, 10) . Two of these structural units, known as the carboxyphosphate (Met 1 -Glu 403 ) and carbamoyl phosphate (Asn 554 -Asn 936 ) synthetic components are homologous to one another and contain all of the catalytic machinery necessary for the final assembly of carbamoyl phosphate. These two synthetase units are linked together by a third domain (Val 404 -Ala 553 ) whose functional role in the structure and catalytic properties of CPS is still not well understood. However, this region of the protein appears to play a role in the oligomerization of the ␣,␤-heterodimer into an (␣,␤) 4 -tetrameric species (1) . The remaining domain (Ser 937 -Lys 1073 ) has been shown by both x-ray crystallographic and biochemical methods to harbor the binding sites for such allosteric effectors as ornithine, UMP, and IMP.
The binding site for the positive allosteric effector, ornithine, was identified in the original x-ray structural analysis of CPS (1, 2) . Ornithine was found to straddle the interface between the allosteric domain and the carbamoyl phosphate synthetic component. Specifically, the ␣-amino group of this compound was shown to lie within hydrogen bonding distance to O ␥ of Tyr 1040 in the allosteric domain, whereas the ␦-amino group was positioned within 3.0 Å from the carboxylate groups of Glu 783 and Glu 892 , and O of Asp 791 , all of which originate from the carbamoyl phosphate synthetic component. In addition, the carboxylate group of ornithine was observed interacting with both the backbone amide nitrogen and O ␥ of Thr 1042 . This same structure of CPS also provided the first hint for the locations of the nucleotide monophosphate binding sites. Indeed, within the allosteric domain, an inorganic phosphate was observed, hydrogen bonded, and ion-paired to Lys 954 , Thr 974 , Thr 977 , and Lys 993 . The hydroxyl group of Thr 977 had previously been shown to be critical for the display of the allosteric properties of UMP (11) , although somewhat later Lys 993 was shown to be the residue modified upon photolabeling CPS with UMP (12). From the above mentioned data, a structural model was subsequently proposed by Thoden IMP to the allosteric domain of the large subunit. Relative to UMP, the allosteric properties exhibited by IMP are rather modest. Originally, IMP was described as an activator of CPS (13-15) but Reinhart and colleagues (7) elegantly demonstrated that the net allosteric effects of IMP can be modulated by temperature. At high temperatures, IMP activates CPS, whereas at lower temperatures the enzymatic activity is depressed. From past investigations (13, 14, 16) , it was suggested that both IMP and UMP compete for the same binding site. More recently, it has been demonstrated quantitatively that the allosteric effects exhibited by IMP and UMP are strictly competitive with one another (17) . These results are fully consistent with a common binding site for these two nucleotide monophosphate molecules. In contrast, ornithine and either IMP or UMP can bind simultaneously to CPS but the activation properties of ornithine completely dominate the inhibitory effects of either IMP or UMP (17) .
Here we report the first structural analysis of the nucleotide monophosphate allosteric binding site for CPS from E. coli. For this investigation, CPS was crystallized in the presence of both IMP and ornithine. The IMP binding site was found to be contained wholly within the allosteric domain of CPS in a position consistent with previous biochemical data. The model presented here provides one snapshot along the way toward a more complete structural understanding of the allosteric behavior displayed by this remarkable enzyme.
EXPERIMENTAL PROCEDURES
Purification and Crystallization Procedures-Protein employed in this investigation was purified as described previously (18) . For crystallization trials, the protein was concentrated to 4 mg/ml in 10 mM HEPES (pH 7.0) and 100 mM KCl. Large single crystals were grown at 4°C using a precipitant solution containing 0.65 M tetraethylammonium chloride, 8% w/v (polyethylene) glycol 8000, 100 mM KCl, 0.5 mM MnCl 2 , 0.5 mM ornithine, 1.25 mM ADP, 1.25 mM BeF 3 , 5.0 mM IMP, and 25 mM HEPES (pH 7.4). The crystals took approximately 3 months to achieve maximum dimensions of 1.2 ϫ 0.5 ϫ 0.4 mm. As in previous structural analyses of CPS from E. coli, these crystals belonged to the space group P2 1 2 1 2 1 with unit cell dimensions of a ϭ 152.1 Å, b ϭ 163.9 Å, and c ϭ 331.2 Å and one (␣,␤) 4 -heterotetramer per asymmetric unit.
X-ray Data Collection and Processing-Before x-ray data collection, the crystals were transferred to a cryoprotectant solution as described previously and subsequently flash-cooled to Ϫ150°C in a stream of nitrogen gas (2) . X-ray data to 2.1 Å resolution were collected at the Stanford Synchrotron Radiation Laboratory on beam-line 7-1 with the MAR300 image plate system. A low resolution x-ray data set, consisting of eighty "1 o " frames with the direct beam centered on the detector and a crystal-to-detector distance of 420 mm, was collected first. These frames were collected with a constant number of photons per frame. The detector was then translated up into its offset position, again at a crystal-to-detector distance of 420 mm. A total of 320 "0.7 o " frames was 
is the observed structure-factor amplitude, and F c is the calculated structure-factor amplitude.
b The torsional angles were not restrained during the refinement.
collected. These frames were processed with DENZO and scaled with SCALEPACK (19) . From 3,249,722 measurements, 1,855,323 reflections were integrated and reduced to 445,013 unique reflections after scaling. Scaling statistics are presented in Table I . The structure of the CPS⅐IMP complex described here was solved by the technique of molecular replacement (20) with the software package AMORE (21) and using, as a search model, the complete tetrameric form of CPS previously refined to 2.1 Å resolution (2) . Following rigid body refinement, the model was subjected to least squares refinement at 2.1 Å resolution with the software package TNT (22) . Because there were over 5,800 amino acid residues in the asymmetric unit, the model building and refinement processes were expedited by averaging the electron densities corresponding to the four ␣,␤-heterodimers in the asymmetric unit as described previously (23) . Alternate cycles of rebuilding using this averaged electron density map followed by least squares refinement of the "averaged" model expanded back into the unit cell reduced the R cryst to 20.8% and the R free to 26.5%. For calculation of R free , 5% of the x-ray data were removed from the reflection file. At this point the entire tetrameric model was adjusted in the unit cell and an additional cycle of least squares refinement conducted leading to an R cryst of 19.2% and an R free of 25.7%. A final cycle of refinement was conducted with all measured x-ray data from 30 to 2.1 Å resulting in an R-factor of 19.3%. Relevant refinement statistics are presented in Table  II . The CPS⅐IMP model described here includes eight ADP molecules, 12 manganese ions, 8 ornithines, 4 inorganic phosphates, 28 potassium ions, 12 chloride ions, 4,037 water molecules, 4 tetraethylammonium ions, and 4 IMP molecules. The following side chains were modeled as multiple conformations: Ser 29 , Arg 130 , Glu 278 , Asp 416 , Glu 655 , Glu 910 , Gln 967 , and Glu 983 in the large subunit and Arg 215 in the small subunit of ␣,␤-heterodimer I; Arg 145 in the large subunit and Met 286 in the small subunit of ␣,␤-heterodimer II; Arg 82 , Arg 222 , Arg 490 , Arg 559 , Glu 591 , Lys 634 , Gln 645 , Arg 652 , Glu 771 , Lys 941 , Glu 1009 , and Arg 1021 in the large subunit and Gln 78 in the small subunit of ␣,␤-heterodimer III and Lys 35 and Glu 478 in the large subunit of ␣,␤-heterodimer IV. In addition, Cys 269 was modeled as sulfenic acid for all four small subunits contained within the asymmetric unit.
RESULTS AND DISCUSSION
The CPS crystals employed in this investigation contained a complete (␣,␤) 4 -heterotetramer in the asymmetric unit. Because the four (␣,␤)-heterodimers are strikingly similar, however, the following discussion will refer only to (␣,␤)-heterodimer II as deposited in the Brookhaven Protein Data Bank. Shown in Fig. 2 is the electron density corresponding to the IMP ligand. The nucleotide fits the electron density best with the ribose in the C 2Ј -endo conformation. The purine ring adopts an anti-orientation and is tilted by approximately 156 o from the plane of the ribose ring. This is in sharp contrast to those conformations observed for the ADP moieties bound to CPS whereby the bases are tilted by approximately 128 o and the ribose rings adopt C 3Ј -endo puckers. All the nucleotide monophosphates contained within the crystallographic asymmetric unit are very well ordered with the IMP bound to (␣,␤)-heterodimer II having an average temperature factor of 30.5 Å 2 .
The allosteric domain of CPS (Ser 937 to Lys 1073 ) is characterized by a five-stranded parallel ␤-sheet flanked on either side by two and three ␣-helices, respectively. As can be seen in Fig. 2 , the IMP ligand is situated at the C-terminal end of this sheet and, indeed, is completely contained within the allosteric domain as originally predicted (1) . A close-up view of the IMP binding pocket is displayed in Fig. 3a and a cartoon of potential hydrogen bonds between the ligand and the protein is shown in Fig. 3b . As indicated by the gray spheres in Fig. 3a , there are three water molecules located within a 5 Å sphere of the purine nucleotide. One side of the hypoxanthine ring is packed against a fairly hydrophobic pocket formed by Ile 1001 , Val 1028 , and Ile 1029 . The only direct electrostatic contact between the purine base and the protein occurs between O-6 of the hypoxanthine ring and N of Val 994 . A water molecule is located within 3.0 Å to N-1 of the purine base. Both N ␦2 of Asn 1015 and O ␥ of Thr 1017 serve to anchor the 2Ј-OH group of the ribose to the protein. The 3Ј-OH group of the ribose lies within hydrogen bonding distance to O of Thr 1016 . All three phosphoryl oxygens form direct hydrogen bonds with the protein via the side chain functional groups of Lys 954 , Thr 974 , Thr 977 , and Lys 993 as indicated by the dashed lines in Fig. 3b . In addition, the backbone amide groups of Gly 976 and Thr 977 also lie within hydrogen bonding distance to two of the phosphoryl oxygens. Approximately 90% of the surface area for the nucleotide ligand is buried upon binding to CPS as calculated with the program GRASP and employing a search radius of 1.4 Å (24).
The original structure of CPS was solved in the presence of both Mn 2ϩ ADP and ornithine to 2.8 Å resolution (1) . In that model, two ornithine binding sites per ␣,␤-heterodimer were identified. The first ornithine was shown to bridge the C-domain of the carbamoyl phosphate synthetic component to the allosteric domain. The second ornithine, along with an inorganic phosphate, was positioned at the C-terminal end of the phate. The model described in this report is shown in black, whereas the structure of CPS complexed with glutamine and inorganic phosphate, as described by Thoden et al. (2) , is displayed in red. Note the nearly exact correspondence between the inorganic phosphate and the phosphoryl moiety of the nucleotide. tamine in an attempt to label the active site of the small subunit. Although the glutamine did not bind in the active site in this study, it did, however, displace the ornithine from its binding pocket in the allosteric domain (2) .
A superposition of this ligand binding site, as observed in the refined structure of CPS, onto the present CPS⅐IMP model is depicted in Fig. 4 . The phosphoryl group of the nucleotide occupies a nearly identical position to that observed for the inorganic phosphate. This phosphate binding region is positioned at the N-terminal region of an ␣-helix formed by Thr 974 to Gly 982 . It can thus be speculated that both hydrogen bonds and electrostatic interactions with the positive end of the helix dipole serve to promote binding of phosphate moieties to this region of the allosteric domain. The only two side chains that adopt significantly different conformations between the two models are Ile 1001 and Ile 1029 where their dihedral angles differ by approximately 120 -130 o . Other than these side chains, the two CPS complexes are remarkably similar, such that 5,744 of their backbone atoms coincide with a root mean square deviation of 0.31 Å. Recently, Bueso et al. (25) demonstrated that IMP bound to CPS can be photocrosslinked to the large subunit in very low yield. The only amino acid residue labeled after photoirradiation was shown to be His 995 . Site-directed mutagenesis of His 995 to an alanine residue had relatively little effect on either the catalytic or regulatory properties of CPS. In the crystal structure of the CPS⅐IMP complex reported here, the imidazole ring of His 995 is approximately 4 Å from the hypoxanthine ring of the nucleotide monophosphate. The biochemical results of Bueso et al. (25) are thus entirely consistent with the fact that His 995 does not significantly contribute to the binding site for IMP.
In CPS, the IMP ligand binds to the C-terminal portion of a parallel ␤-sheet. A search of the Brookhaven Protein Data Bank reveals that other enzymes have been solved in the presence of IMP, or analogs thereof, including adenoylsuccinate synthetase (26) . Detailed x-ray crystallographic analyses of this enzyme have demonstrated that the IMP ribose adopts the C 2Ј -endo pucker with the purine base oriented similarly to that observed in CPS (26) . Additionally, the phosphoryl group of the nucleotide is positioned within approximately 5 Å of the Nterminal end of an ␣-helix formed by Gly 132 to Ala 142 . The IMP moiety is deeply buried within the protein such that only about 1% of its surface area is exposed to the solvent. Unlike that observed in CPS, the purine ring makes numerous hydrogen bonding contacts with the protein. Note that adenoylsuccinate synthetase catalyzes the production of adenoylsuccinate from IMP, aspartate, and GTP, and in this case, the nucleotide monophosphate is a true substrate. With regard to the role of IMP acting solely as an effector molecule, however, the only other observed structural example of IMP binding within an allosteric pocket is that of glycogen phosphorylase (27) . In this enzyme, the ribose of the nucleotide adopts the C 3Ј -endo pucker. The ligand is positioned in a rather open region of the molecule with approximately 48% of its surface area exposed to the solvent, the hypoxanthine ring facing outwards and no direct protein contacts to the base. Other than the similarities in ribose puckers between CPS and adenoylsuccinate synthetase, the tertiary motifs employed for IMP binding in these three enzymes are quite different.
The overall spatial relationships between the active sites of the small and large subunits of CPS and the IMP and ornithine effector binding pockets are depicted in Fig. 5 . The ornithine and IMP binding sites are separated by approximately 12 Å, whereas the ornithine binding region and active site in the carbamoyl phosphate synthetic component are situated approximately 14 Å apart. Previously, it was demonstrated that allosteric ligands such as IMP and ornithine affect the carbamoyl phosphate-dependent ATP synthesis reaction more so than the other two partial reactions catalyzed by CPS (7) . The manner in which the IMP allosteric effector site communicates to this Mg 2ϩ ATP binding site is most likely via a complicated series of hydrogen bonds. As an example, there is a hydrogen bonding pathway leading directly from the 2Ј-hydroxyl group of the IMP ribose to one of the phosphoryl oxygens of the Mn 2ϩ ADP. This hydrogen bonding network initiates via the interaction between N ␦2 of Asn 1015 and the 2Ј-hydroxyl group of IMP (Fig. 3b) chain of His 788 hydrogen bonds to a phosphoryl oxygen of the Mn 2ϩ ADP moiety. Examination of the CPS⅐IMP complex model described in this report demonstrates that additional hydrogen bonding networks may also exist between the IMP binding pocket and the active site of the carbamoyl phosphate synthetic component.
From previous biochemical studies (13, 14, 16) , it is known that IMP and UMP compete for the same binding site on CPS. It can thus be speculated that the structure of CPS described here reveals not only the manner in which IMP is accommodated on the enzyme but also the mode of UMP binding to the allosteric domain, at least as far as the phosphoryl and sugar moieties are concerned. Recent detailed kinetic analyses of the behavior of CPS in the presence of IMP, UMP, or ornithine or combinations thereof have revealed a quite complicated set of catalytic behaviors (17) . In addition, these studies have demonstrated that though both ornithine, an activator, and UMP, an inhibitor, can bind simultaneously to CPS, the activating effect of ornithine on the catalytic activity of CPS clearly prevails. What is not apparent from the present structural studies is the manner in which the enzyme discriminates between UMP and IMP. It would appear likely that the same molecular contacts are made to the ribose-phosphate moieties of UMP and IMP in the bound complexes. However, in the structure of IMP complexed to CPS, relatively few contacts are made to the hypoxanthine ring system. We anticipate that a significant molecular rearrangement occurs upon the binding of UMP to CPS that is not observed in the present model. These structural manifestations can only be elucidated via a combination of biochemical and x-ray crystallographic experiments and, indeed, these investigations are in progress.
